Materias dentro de su búsqueda.
Mostrando 1,321 - 1,340 Resultados de 15,180 Para Buscar '"Hepatitis C"', tiempo de consulta: 0.39s Limitar resultados
  1. 1321
    “…All patients with GBS should be tested for hepatitis C, or its reactivation if already present, and followed up for an early diagnosis and treatment.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Guillain-Barré syndrome as clinical presentation of a recently acquired hepatitis C
  2. 1322
    “…INTRODUCTION: In the United States, the hepatitis C virus (HCV) is a leading contributor to liver-related illnesses and fatalities. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hepatitis C Prevalence on the Rise but Screening at Safety Net Institutions Lagging behind
  3. 1323
    “…INTRODUCTION: A pan-genotypic and effective treatment regimen for patients with chronic hepatitis C virus (HCV) infection remains an unmet medical need in China. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China
  4. 1324
    por Aslam, Samia, Yan, Peng, Butt, Adeel A
    Publicado 2023
    “…BACKGROUND: There are contradicting reports regarding the relationship between hepatitis C virus (HCV) infection and its treatment with idiopathic Parkinson’s Disease (PD). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2491. The Association of Parkinson’s Disease with Hepatitis C Virus Infection and Its Treatment
  5. 1325
    “…BACKGROUND: According to the WHO, approximately 71 million people are infected with Hepatitis C virus (HCV), and more than 400,000 people die each year due to HCV-related liver diseases. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2490. Improving Hepatitis C Continuum of Care in an Outpatient Internal Medicine Population
  6. 1326
    “…BACKGROUND: Direct-acting antiviral (DAA) treatment for hepatitis C viral infection (HCV) is typically initiated in the outpatient setting. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2492. Implementation of a Hepatitis C Referral Workflow: A Pilot Program
  7. 1327
    “…We conducted a rapid review to understand hepatitis C-specific antibody (anti-HCV) and HCV RNA test positivity in antenatal settings in the United Kingdom to inform guidance. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A rapid review of antenatal hepatitis C virus testing in the United Kingdom
  8. 1328
    por Crockett, Seth D, Keeffe, Emmet B
    Publicado 2005
    “…Hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection is not uncommon as a result of similar routes of infection. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection
  9. 1329
    “…BACKGROUND: Hepatitis C virus (HCV) infection and schistosomiasis are major public health problems in the Nile Delta of Egypt. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt
  10. 1330
    por Liu, Zhihua, Hou, Jinlin
    Publicado 2006
    “…Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections account for a substantial proportion of liver diseases worldwide. …”
    Enlace del recurso
    Enlace del recurso
    Texto
    Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Dual Infection
  11. 1331
    “…BACKGROUND: Both uremia and hepatitis C infection is associated with increased oxidative stress. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Oxidative stress in hepatitis C infected end-stage renal disease subjects
  12. 1332
    “…BACKGROUND: The mechanisms leading to hepatic injury in chronic hepatitis C virus (HCV) infection are only incompletely understood. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Semiquantitative analysis of intrahepatic CC-chemokine mRNas in chronic hepatitis C.
  13. 1333
    “…We describe the first case of a patient on methadone who received a liver transplant for end stage liver disease and was successfully treated for recurrent hepatitis C. More than five years post transplant and three years post viral clearance, the patient continues to do well and is stable on low-dose methadone. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Liver transplant and hepatitis C in methadone maintenance therapy: a case report
  14. 1334
    “…BACKGROUND/AIM: The role of humoral immunity in hepatitis C virus (HCV) infection is poorly understood. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
  15. 1335
    por Ye, Jin
    Publicado 2007
    “…Hepatitis C virus (HCV), a single-stranded positive-sense RNA virus of the Flaviviridae family, infects more than 170 million people worldwide and is the leading cause of liver failure in the United States. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Reliance of Host Cholesterol Metabolic Pathways for the Life Cycle of Hepatitis C Virus
  16. 1336
    “…To identify potential biomarkers of fibrosis, we compared serum protein expression profiles in patients with chronic hepatitis C (CHC) virus infection and fibrosis. METHODS: Twenty-one patients with no or mild fibrosis (METAVIR stage F0, F1) and 23 with advanced fibrosis (F3, F4) were retrospectively identified from a pedigreed database of 1600 CHC patients. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection
  17. 1337
    “…The virological and immunological features of hepatitis C virus (HCV) infection were studied weekly for 6 months after accidental needlestick exposure in five health care workers, four of whom developed acute hepatitis that progressed to chronicity while one subject cleared the virus. …”
    Enlace del recurso
    Enlace del recurso
    Texto
    Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection
  18. 1338
    “…The overall prevalence in south and east Africa region has been estimated to be 1.6% but limited information about the epidemiology of HCV infection in Madagascar is available METHODS: A cross-sectional survey for hepatitis C antibodies was conducted in 2,169 subjects of the general population of Antananarivo to determine seroprevalence of hepatitis C and associated risk factors. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Seroprevalence of hepatitis C and associated risk factors in urban areas of Antananarivo, Madagascar
  19. 1339
    por Paydas, S, Kiliç, B, Sahin, B, Buğdayci, R
    Publicado 1999
    “…Anti-hepatitis C virus (HCV) antibody prevalence was investigated in 228 patients with lymphoproliferative disorders (LPDs). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey
  20. 1340
    “…We examined whether MBL2 variants influence the outcome of hepatitis C virus (HCV) infection. METHODS: Participants were enrolled in the Urban Health Study of San Francisco Bay area injection drug users (IDU) during 1998 through 2000. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    MBL2 and Hepatitis C Virus Infection among Injection Drug Users
Herramientas de búsqueda: RSS